Kv1.5 Inhibition in Atrial Fibrillation: Molecular Mechanisms, Translational Challenges, and Implications for Equitable Rhythm Control
Cardiovascular Science · 2026 · 3 (2) · 10007-10007
DOI: 10.70322/cvs.2026.10007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Science, 2026. Verfasst von M. Molitor Frankie und 3 weiteren Autor:innen. Die Arbeit nennt 139 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Frankie, M. M., Abisola, M. O., Oluwaseun, A. A., & Natalya, S. Z. (2026). Kv1.5 Inhibition in Atrial Fibrillation: Molecular Mechanisms, Translational Challenges, and Implications for Equitable Rhythm Control. Cardiovascular Science, 3(2), 10007-10007. https://doi.org/10.70322/cvs.2026.10007
Vancouver
Frankie MM, Abisola MO, Oluwaseun AA, Natalya SZ. Kv1.5 Inhibition in Atrial Fibrillation: Molecular Mechanisms, Translational Challenges, and Implications for Equitable Rhythm Control. Cardiovascular Science. 2026;3(2):10007-10007. doi:10.70322/cvs.2026.10007
BibTeX
@article{Frankie2026,
author = {Frankie, M. Molitor and Abisola, M. Olowofeso and Oluwaseun, A. Afolabi and Natalya, S. Zinkevich},
title = {Kv1.5 Inhibition in Atrial Fibrillation: Molecular Mechanisms, Translational Challenges, and Implications for Equitable Rhythm Control},
journal = {Cardiovascular Science},
year = {2026},
volume = {3},
number = {2},
pages = {10007--10007},
doi = {10.70322/cvs.2026.10007}
}
EUVIMED